Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global biological safety testing market size was valued at USD 4.53 billion in 2023, driven by the increasing number of cases of infectious diseases across the globe. The market size is anticipated to grow at a CAGR of 13.2% during the forecast period of 2024-2032 to achieve a value of USD 13.82 billion by 2032.
Biological safety testing refers to a set of procedures and assessments conducted to ensure the safety of biopharmaceuticals, medical devices, and other products derived from biological sources. This testing aims to evaluate potential risks associated with these products, including contamination and adverse biological effects, ensuring compliance with regulatory standards. Techniques such as sterility testing, endotoxin testing, and cell-based assays are employed to assess the purity, potency, and safety of biological materials.
By rigorously examining these factors, biological safety testing guarantees the integrity and quality of biologically derived products, safeguarding public health and adhering to regulatory guidelines in the pharmaceutical and healthcare industries.
The increasing number of biopharmaceutical firms and laboratories in the market is one of the major factors bolstering the market growth. With more biopharmaceutical firms and laboratories, the market is also expected to experience an increase in the production of new biologics, which will further contribute to the rising biological safety testing market demand.
The recent strategic moves by Charles River Laboratories International, Inc. (CRL) and Merck are poised to significantly contribute to the growth of the global market for biological safety testing during the forecast period. Charles River's acquisition of SAMDI Tech, a provider of label-free high-throughput screening solutions for drug discovery research, expands its capabilities in biochemical analysis and binding interaction identification. This move aligns with the increasing demand for advanced technologies in drug development, driving the adoption of high-quality screening solutions.
The market growth is fostered by the rising interest of key players in investing in research and development activities. For example, Merck's substantial investment of 35 million euros in biosafety testing at its Glasgow and Stirling sites in Scotland underscores the industry's commitment to ensuring the safety and efficacy of pharmaceutical products. The expansion not only enhances Merck's capacity for biosafety testing but also creates job opportunities, reflecting a positive economic impact, and bolstering the global biological safety testing market growth.
These strategic initiatives collectively contribute to the strengthening of capabilities in drug development and manufacturing, emphasizing the importance of rigorous biosafety testing. As the pharmaceutical industry continues to advance, the global market is expected to experience growth, driven by increased demand for safety assurance in drug development processes and adherence to regulatory standards.
Market Breakup by Product Type
Market Breakup by Test
Market Breakup by Application
Market Breakup by Region
The market is driven by the increased research and development activities in the pharmaceuticals and biotechnology field. The increasing awareness of the benefits and importance of quality control in the healthcare sector is a major factor responsible for the market growth. The escalating demand for improved testing methods such as nucleic acid amplification and sequencing techniques and the increasing prevalence of infectious diseases are also driving the global biological safety market growth. The increasing awareness of sterility tests among pharmaceutical and biotechnological firms due to the stringent regulatory guidelines is collectively bolstering the market growth in the forecast period. The increasing production of pharmaceutical products due to the increasing prevalence of infectious medical conditions is a major factor responsible for market growth.
Geographically, North America is leading the market and is expected to drive the market in the forecast period. The regional market can be attributed to the increasing presence of biotechnology and pharmaceutical companies due to rising innovative technologies and the presence of favourable government initiatives.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Test |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
The market attained a value of about USD 4.53 billion in 2023, driven by increased investments in the market.
The market is anticipated to grow at a CAGR of 13.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 13.82 billion by 2032.
The increasing number of biopharmaceutical firms and laboratories, along with the increasing awareness about the importance of biological safety and product sterility, are among the major factors driving the market growth.
Increasing acquisitions and investments by key players are among the key trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Different product types include instruments, reagents and kits, among other products.
Different tests in the market can be categorised into sterility tests, bioburden tests, and endotoxin tests, among others.
They find wide applications in vaccines and therapeutics, cellular and gene therapy, blood and blood-based therapy, among other applications.
Key players involved in the market are Avance Biosciences, Cytovance Biologics, Eurofins Scientific, Lonza, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Toxikon, WuXi AppTec, Biomerieux SA, Nelson Laboratories, LLC, Almac Group, GenScript, InvivoGen, and Maravai LifeSciences.
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Pricing Plans
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124